GO:0003725 double-stranded RNA binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003725 double-stranded RNA binding is a molecular function defined as binding to double-stranded RNA (dsRNA).
• dsRNA binding is central to RNA interference, innate antiviral immunity, and nucleocytoplasmic transport.
• Key dsRNA-binding proteins include RIG-I, PKR, ADAR, Dicer, and many others that recognize dsRNA via specialized domains.
• Dysregulation of dsRNA binding contributes to cancer, neurodegeneration, and autoimmune diseases.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable functional dissection of dsRNA-binding proteins.
• EDITGENE provides comprehensive CRISPR services to study dsRNA-binding proteins and their roles in disease.
Description
Double-stranded RNA (dsRNA) is a common intermediate in viral replication and a potent trigger of cellular defense mechanisms. The molecular function of double-stranded RNA binding (GO:0003725) encompasses the selective recognition of dsRNA by proteins, a process essential for RNA interference (RNAi), innate immunity, and RNA processing. Since the discovery of RNAi in Caenorhabditis elegans, dsRNA-binding proteins have emerged as critical regulators of gene expression and antiviral responses. Understanding how these proteins recognize dsRNA is fundamental to both basic biology and therapeutic development. Researchers studying dsRNA binding often employ CRISPR-based genome editing to dissect the roles of specific domains and residues. This article provides a comprehensive overview of GO:0003725, covering its definition, mechanisms, key genes, disease relevance, and experimental approaches.
double-stranded RNA binding At A Glance
| GO ID | GO:0003725 |
|---|---|
| GO term | double-stranded RNA binding |
| Ontology | molecular_function |
| Synonym | dsRNA binding |
| Major function | Binding to double-stranded RNA, often via dsRNA-binding domains (dsRBM) |
| Related processes | RNA interference, innate immune response, nucleocytoplasmic transport |
| Key proteins | RIG-I, PKR, ADAR, Dicer, TRBP, PACT, Staufen |
| Disease relevance | Cancer, viral infections, neurodegenerative disorders, autoimmune diseases |
What Is GO:0003725?
According to the Gene Ontology, GO:0003725 double-stranded RNA binding is defined as the binding to double-stranded RNA. This molecular function is mediated by specialized domains such as the dsRNA-binding motif (dsRBM) found in many proteins. It is distinct from single-stranded RNA binding and is critical for processes like RNA interference, where dsRNA triggers sequence-specific gene silencing.
Why Is double-stranded RNA binding Important in Cell Biology?
Double-stranded RNA binding is a fundamental molecular function that underpins diverse biological processes, from antiviral defense to gene regulation. Proteins that bind dsRNA are essential for recognizing foreign genetic material and initiating immune responses, as well as for processing cellular RNAs. Dysregulation of these proteins can lead to severe diseases, including cancer and neurodegeneration. Thus, understanding dsRNA binding is crucial for developing therapeutics and advancing molecular biology.
• dsRNA binding is the first step in RNA interference, a conserved gene-silencing mechanism.
• It enables innate immune sensing of viral infections by receptors like RIG-I.
• dsRNA-binding proteins regulate RNA editing, splicing, and transport.
• Mutations in dsRNA-binding domains are linked to cancer and autoimmune disorders.
• dsRNA binding is exploited in biotechnology for gene knockdown and therapeutics.
• It plays a role in mitochondrial RNA degradation and cytosolic release.
• Exosomal dsRNA-TLR3 signaling in pain modulation involves dsRNA binding.
• Insect dsRNA-binding proteins affect RNAi efficiency, impacting pest control.
• Peptide nucleic acids can be designed to selectively bind dsRNA for therapeutic applications.
• Nucleocytoplasmic transport of RNA is regulated by dsRNA-binding domains.
Molecular Mechanism of double-stranded RNA binding
Recognition of dsRNA by dsRBM domains
In simple terms: Proteins use special domains to grab onto double-stranded RNA.
The dsRNA-binding motif (dsRBM) is a conserved domain that recognizes the A-form helix of dsRNA without sequence specificity. This binding is mediated by interactions between the domain and the minor groove of dsRNA, as well as phosphate backbone contacts. Proteins such as PKR and TRBP contain multiple dsRBM domains that cooperate for high-affinity binding.
Activation of innate immune signaling
In simple terms: When proteins bind viral dsRNA, they trigger an alarm in the cell.
RIG-I is a cytosolic RNA helicase that binds short dsRNA with 5'-triphosphate ends, leading to conformational changes and activation of MAVS-dependent antiviral signaling. This binding is essential for interferon production and host defense.
RNA interference and gene silencing
In simple terms: dsRNA can silence genes by matching their sequence.
In RNAi, long dsRNA is processed by Dicer into small interfering RNAs (siRNAs), which are loaded into the RNA-induced silencing complex (RISC). The dsRNA-binding protein TRBP assists in RISC assembly and target recognition.
RNA editing and modification
In simple terms: Some proteins change the sequence of RNA after binding it.
ADAR enzymes bind dsRNA and catalyze adenosine-to-inosine editing, which alters RNA sequence and function. This editing is crucial for neuronal function and immune regulation.
Nucleocytoplasmic transport
In simple terms: dsRNA-binding proteins help move RNA out of the nucleus.
Proteins with dsRBM domains, such as Staufen, are involved in the nucleocytoplasmic transport of RNA, influencing mRNA localization and translation.
Mitochondrial dsRNA degradation
In simple terms: dsRNA in mitochondria is marked for destruction to prevent immune activation.
RNA 5-methylcytosine modification marks mitochondrial dsRNAs for degradation, preventing their release into the cytosol where they could trigger immune responses.
Key Genes Involved in GO:0003725 double-stranded RNA binding
The following genes encode proteins that bind double-stranded RNA and are critical for various cellular processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RIG-I (DDX58) | Cytosolic sensor of viral dsRNA | Innate immunity, antiviral therapy |
| PKR (EIF2AK2) | dsRNA-activated protein kinase | Translation inhibition, antiviral defense |
| ADAR | dsRNA-specific adenosine deaminase | RNA editing, neuronal function |
| Dicer (DICER1) | Ribonuclease that processes dsRNA | RNAi, microRNA biogenesis |
| TRBP (TARBP2) | dsRNA-binding protein in RISC | RNAi, HIV replication |
| PACT (PRKRA) | dsRNA-binding protein | PKR activation, stress response |
| Staufen (STAU1) | dsRNA-binding protein | mRNA transport, localization |
| TLR3 | dsRNA receptor | Innate immunity, pain modulation |
| MDA5 (IFIH1) | Cytosolic dsRNA sensor | Antiviral immunity |
| LGP2 (DHX58) | dsRNA-binding regulator | RIG-I signaling modulation |
| OAS1 | dsRNA-activated enzyme | Antiviral response |
| RNase L (RNASEL) | dsRNA-activated nuclease | Antiviral and apoptotic pathways |
| P58IPK (DNAJC3) | dsRNA-binding protein | Influenza virus replication |
| NF90 (ILF3) | dsRNA-binding protein | RNA stability, splicing |
| NF45 (ILF2) | dsRNA-binding protein | Complex with NF90 |
| ZBP1 (DLM1) | dsRNA-binding protein | Innate immunity, necroptosis |
| TRIM25 | dsRNA-binding E3 ligase | RIG-I ubiquitination |
How Is double-stranded RNA binding Regulated?
The activity of dsRNA-binding proteins is regulated at multiple levels. For example, RIG-I is regulated by ubiquitination and phosphorylation, which control its conformational activation upon dsRNA binding. PKR is regulated by autophosphorylation and dimerization induced by dsRNA. ADAR activity is modulated by its dsRNA-binding domains and cellular localization. Additionally, mitochondrial dsRNA degradation is regulated by RNA modifications such as 5-methylcytosine.
double-stranded RNA binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ADAR | Cancer, ALS, autoimmune disorders | Knockout and point mutation cell lines |
| DICER1 | Pleuropulmonary blastoma, ovarian cancer | Knockout and knock-in models |
| RIG-I | Viral infections, autoimmune diseases | Overexpression and knockout models |
| TLR3 | Neuroinflammation, morphine tolerance | Knockout and overexpression models |
| STAU1 | Neurodegeneration, mRNA transport defects | Knockout and tagged knock-in |
Cancer
Dysregulation of dsRNA-binding proteins is implicated in cancer. For instance, ADAR editing can promote tumorigenesis by altering oncogene and tumor suppressor transcripts. Dicer mutations are associated with pleuropulmonary blastoma and other cancers. Targeting dsRNA-binding proteins is a potential therapeutic strategy.
Neurodegenerative disorders
ADAR dysfunction leads to aberrant RNA editing and is linked to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer's disease. Staufen-mediated mRNA transport defects contribute to neuronal dysfunction.
Autoimmune and inflammatory diseases
Exosomal dsRNA-TLR3 signaling contributes to morphine tolerance and hyperalgesia, suggesting a role in neuroinflammation. Mitochondrial dsRNA release can trigger autoimmune responses if not properly degraded.
Viral infections
Many viruses encode dsRNA-binding proteins to evade host immunity. RIG-I and MDA5 are critical for detecting viral dsRNA, and their dysregulation increases susceptibility to infections.
From double-stranded RNA binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of dsRNA-binding protein affect RNAi? | CRISPR knockout cell lines |
| How do point mutations in dsRBM affect binding? | CRISPR point mutation knock-in |
| Where does the protein localize? | Tagged knock-in (e.g., GFP) |
| Does overexpression enhance antiviral response? | CRISPR overexpression (e.g., SAM) |
| What are the downstream targets? | Knockout followed by RNA-seq |
| Can we rescue a disease phenotype? | Knock-in of wild-type vs mutant |
How to Study the double-stranded RNA binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RIP-seq | Protein-dsRNA interactions | Mapping binding sites |
| EMSA | Direct binding affinity | Validating dsRNA binding in vitro |
| CRISPR knockout screen | Gene essentiality for dsRNA response | Identifying novel dsRNA-binding proteins |
| RNA-seq | Transcriptome changes | Assessing downstream effects |
| A-to-I editing assay | ADAR activity | Measuring RNA editing |
| Immunofluorescence | Protein localization | Visualizing dsRNA-binding proteins |
| Western blot | Protein expression and phosphorylation | Validating knockout/overexpression |
| Luciferase reporter | Interferon signaling activation | Measuring innate immune response |
RNA immunoprecipitation (RIP) and CLIP
RIP and CLIP techniques identify dsRNA sequences bound by specific proteins in vivo, revealing binding sites and motifs.
Electrophoretic mobility shift assay (EMSA)
EMSA measures direct binding of purified proteins to dsRNA probes, allowing quantification of affinity and specificity.
CRISPR screening
Genome-wide CRISPR knockout screens can identify genes required for dsRNA sensing and RNAi, uncovering novel components.
RNA sequencing and editing analysis
RNA-seq and specialized editing detection methods (e.g., for A-to-I editing) assess the impact of dsRNA-binding proteins on transcriptomes.
How CRISPR Can Be Used to Study GO:0003725 double-stranded RNA binding
Knockout
CRISPR knockout of dsRNA-binding protein genes (e.g., RIG-I, ADAR) abolishes their function, enabling studies of their roles in RNAi, immunity, and disease.
Point Mutation
Introducing point mutations in dsRNA-binding domains (e.g., in PKR or RIG-I) allows precise dissection of residues critical for dsRNA binding and downstream signaling.
Knock-in
Knock-in of tagged versions (e.g., GFP, FLAG) of dsRNA-binding proteins facilitates localization, interaction, and purification studies.
Overexpression
Overexpression of dsRNA-binding proteins (e.g., TRBP, ADAR) can enhance or perturb RNAi and immune responses, revealing gain-of-function phenotypes.
How EDITGENE Supports double-stranded RNA binding Research
Researchers studying double-stranded RNA binding-related genes often need to determine whether a candidate gene is causally involved in a specific process or disease. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic manipulation and functional interrogation of dsRNA-binding proteins.
Contact EDITGENE today to design your custom CRISPR model for double-stranded RNA binding research.
Frequently Asked Questions About double-stranded RNA binding
What is double-stranded RNA binding?
Double-stranded RNA binding is a molecular function (GO:0003725) where proteins selectively recognize and bind to dsRNA, often via specialized domains like dsRBM.
What genes are involved in double-stranded RNA binding?
Key genes include RIG-I (DDX58), PKR (EIF2AK2), ADAR, Dicer (DICER1), TRBP (TARBP2), and many others.
How does double-stranded RNA binding relate to RNA interference?
dsRNA binding is the first step in RNAi, where proteins like Dicer and TRBP recognize and process dsRNA into siRNAs for gene silencing.
What diseases are associated with double-stranded RNA binding?
Dysregulation is linked to cancer, neurodegenerative disorders, autoimmune diseases, and viral infections.
What are the methods to study double-stranded RNA binding?
Common methods include RIP-seq, EMSA, CRISPR screens, and RNA-seq.
Can CRISPR be used to study double-stranded RNA binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect dsRNA-binding protein functions.
What is the role of RIG-I in double-stranded RNA binding?
RIG-I is a cytosolic sensor that binds viral dsRNA and triggers innate antiviral signaling.
How is double-stranded RNA binding regulated?
It is regulated by post-translational modifications, RNA modifications, and protein-protein interactions.
What is the dsRNA-binding motif (dsRBM)?
The dsRBM is a conserved domain that binds dsRNA in a sequence-independent manner, found in many proteins.
Why is double-stranded RNA binding important for antiviral immunity?
It allows cells to detect viral dsRNA and initiate interferon responses, crucial for host defense.
Conclusion
Double-stranded RNA binding (GO:0003725) is a fundamental molecular function with broad implications in RNA interference, innate immunity, and RNA processing. Understanding its mechanisms and key players is essential for developing therapies against cancer, viral infections, and neurodegenerative diseases. CRISPR-based models provide powerful tools to dissect these functions, and EDITGENE offers comprehensive services to support such research.
References
- 1. Fire A et al.. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.. Nature 391(6669):806-11 PMID: 9486653
- 2. Zielińska A. 2025. Insect double-stranded RNA-binding proteins: structure, function and RNAi efficiency.. J Insect Physiol 167:104910 PMID: 41260292
- 3. Kim S et al.. 2024. RNA 5-methylcytosine marks mitochondrial double-stranded RNAs for degradation and cytosolic release.. Mol Cell 84(15):2935-2948.e7 PMID: 39019044
- 4. Wang B et al.. 2024. Targeting exosomal double-stranded RNA-TLR3 signaling pathway attenuates morphine tolerance and hyperalgesia.. Cell Rep Med 5(10):101782 PMID: 39413734
- 5. Tian B et al.. 2004. The double-stranded-RNA-binding motif: interference and much more.. Nat Rev Mol Cell Biol 5(12):1013-23 PMID: 15573138
- 6. Yoneyama M et al.. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.. Nat Immunol 5(7):730-7 PMID: 15208624
- 7. Zhan X et al.. 2022. Mechanisms and applications of peptide nucleic acids selectively binding to double-stranded RNA.. Biopolymers 113(2):e23476 PMID: 34581432
- 8. Banerjee S et al.. 2014. Functions of double-stranded RNA-binding domains in nucleocytoplasmic transport.. RNA Biol 11(10):1226-32 PMID: 25584639
